Phosphorylation of Chk2 and H2AX during gemcitabine-induced S-phase arrest

William Plunkett , Brett Ewald , Jingxuan Pan , Deepa Sampath
Cancer Research 65 532 -532

2005
S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine.

Zheng Shi , Atsushi Azuma , Deepa Sampath , Ye-Xiong Li
Cancer Research 61 ( 3) 1065 -1072

116
2001
The role of c-jun kinase in the apoptotic response to nucleoside analogue-induced DNA damage

William Plunkett , Deepa Sampath
Cancer Research 60 ( 22) 6408 -6415

29
2000
Histone deacetylase inhibitors activate p73 to target chronic lymphocytic leukemia

Vinay Puduvalli , Michael Keating , William Plunkett , Peter Atadja
Cancer Research 67 4085 -4085

2007
In vitro activity of the HDAC inhibitor Suberoyl anilide hydroxamic acid (SAHA) against gliomas

Vinay K. Puduvalli , Yuanfang Liu , Deepa Sampath
Cancer Research 64 963 -963

2004
Identification and comparison of genes differentially regulated by transcription factors and miRNAs

Amir Asiaee , Samantha Nakayiza , Kevin R. Coombes , Zachary B Abrams
bioRxiv 803643

2019
PRMT5 Initiates an Epigenetic Program That Promotes Progression of Chronic Lymphocytic Leukemia

Robert A Baiocchi , Rosa Lapalombella , Bonnie K. Harrington , Lianbo Yu
Blood 130 2487 -2487

2017
Targeting DNA damage repair functions of two histone deacetylases, HDAC8 and SIRT6, sensitizes acute myeloid leukemia to NAMPT inhibition

Rosa Lapalombella , Shelley Orwick , James S. Blachly , Alice S. Mims
Clinical Cancer Research 27 ( 8) 2352 -2366

13
2021
Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL.

Jennifer A. Woyach , Robert A. Baiocchi , Erin Hertlein , Bonnie Harrington
Journal of Hematology & Oncology 14 ( 1) 1 -5

2021
NAMPT Inhibitor KPT-9274 Selectively Targets Self-Renewal Capacity in Acute Myeloid Leukemia

Shaneice Renee Mitchell , Nicole Grieselhuber , Yerdanos Asemelash , Matthew Cannon
Blood 132 3931 -3931

2018
Using HSP90 Inhibitors to Target DNA Repair Proteins in AML

Janani Ravikrishnan , Tzung-Huei Lai , Shaneice Renee Mitchell , Pei-Jung Wu
Blood 132 5144 -5144

2018
The Aberrantly Expressed Long Noncoding RNA, TRERNA1, Predicts for Aggressive Disease in Chronic Lymphocytic Leukemia

Cecelia R Miller , Amy S. Ruppert , Kevin Coombes , Amy M. Lehman
Blood 126 ( 23) 2911 -2911

2
2015
Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal

Mazin A. Moufarij , Deepa Sampath , Michael J. Keating , William Plunkett
Blood 108 ( 13) 4187 -4193

37
2006
MiRly regulating metabolism

Deepa Sampath
Blood 120 ( 13) 2540 -2541

2
2012
miRNAs and their potential for use against cancer and other diseases

Esmerina Tili , Jean-Jacques Michaille , Varsha Gandhi , William Plunkett
Future Oncology 3 ( 5) 521 -537

97
2007
Targeting BTK through microRNA in chronic lymphocytic leukemia

Arianna Bottoni , Lara Rizzotto , Tzung-Huei Lai , Chaomei Liu
Blood 128 ( 26) 3101 -3112

17
2016
Targeting deubiquitinases in CLL

Deepa Sampath
Blood 130 ( 2) 100 -101

6
2017
Shielding p53 from destruction.

Deepa Sampath
Blood 131 ( 25) 2740 -2741

2018